MALIRID 7.5MG TABLET

MALIRID 7.5MG TABLET belongs to the class 'anti-malarials' primarily used for the treatment of malaria. A disease caused by a plasmodium parasite, transmitted by the bite of infected mosquitoes. The severity of malaria varies based on the species of plasmodium. Symptoms are chills, fever and sweating, usually occurring a few weeks after being bitten. People travelling to areas where malaria is common typically take protective drugs before, during and after their trip. 

MALIRID 7.5MG TABLET contains 'primaquine'. It works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading. In this way MALIRID 7.5MG TABLET used for the prevention of relapse of malaria caused by plasmodium vivax and Plasmodium ovale strains of the parasite.

MALIRID 7.5MG TABLET should be taken as prescribed by your doctor, preferably with a meal to avoid stomach upset and at fixed intervals every day for best results. The dose of MALIRID 7.5MG TABLET can vary depending upon your condition and the severity of the infection. It is recommended to complete medicine and take this medicine as prescribed by your doctor before visiting a malaria-prone area. The common side effects of MALIRID 7.5MG TABLET include rash, vomiting, headache, dizziness, hives, stomach pain, nausea, abdominal pain, itching, heartburn, gastrointestinal discomfort, upper abdominal pain. Everyone need not experience the above side effects. In case of any discomfort, stop the medicine and speak with your doctor.

Before starting MALIRID 7.5MG TABLET, please inform your doctor if you are allergic to MALIRID 7.5MG TABLET. Do not take MALIRID 7.5MG TABLET on your own. MALIRID 7.5MG TABLET is used in caution with Pregnant/breast-feeding mother. MALIRID 7.5MG TABLET is not recommended in patients with heart disease, liver, kidney problems and rheumatoid-arthritis.

MALIRID 7.5MG TABLET belongs to the class 'anti-malarials' primarily used for the treatment of malaria. MALIRID 7.5MG TABLET contains 'primaquine'. It works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading. In this way MALIRID 7.5MG TABLET used for the prevention of relapse of malaria caused by plasmodium vivax and Plasmodium ovale strains of the parasite. MALIRID 7.5MG TABLET can also be given in combination with clindamycin for the treatment of Pneumocystis carinii pneumonia (PCP).

• Rash
• Vomiting
• Headache
• Stomach pain
• Dizziness
• Lightheadedness
• Hives
• Dark-coloured urine
• Abdominal pain
• Confusion
• Weakness
• Itching
• Heartburn
• Nausea
• Gastrointestinal discomfort
• Upper abdominal pain

Before starting MALIRID 7.5MG TABLET, please inform your doctor if you are allergic to MALIRID 7.5MG TABLET. Do not take MALIRID 7.5MG TABLET on your own. MALIRID 7.5MG TABLET is used in caution with Pregnant/breast-feeding mother. MALIRID 7.5MG TABLET is not recommended in patients of heart disease, liver, kidney problems and rheumatoid arthritis. MALIRID 7.5MG TABLET is not recommended in patients of diabetes. MALIRID 7.5MG TABLET is not recommended for use in acutely ill patients suffering from a systemic disease like rheumatoid arthritis and lupus erythematosus. There is a marked decrease in the number of granulocytes in such conditions. MALIRID 7.5MG TABLET is also not recommended for use if you are receiving a medication that can cause anaemia or suppression of the immune system by affecting bone marrow cells as a side effect. Medicine is not recommended for use if you are consuming Quinacrine or any other combination medicine containing quinacrine (anti-malarial drug). Patients should avoid pregnancy during treatment. It is recommended to take this medicine for the entire prescribed duration even when symptoms improve or resolve. Failure to do so might result in drug resistance. Sexually active women can take effective Contraceptive pills and men should use a condom during and 3months after stopping the treatment. MALIRID 7.5MG TABLET should be discontinued immediately when leukopenia (reduced white blood cells) occurs.

• CIPROFLOXACIN
• ASPIRIN
• PYRIMETHAMINE
• TRIMETHOPRIM
• PENICILLAMINE
• PHENYTOIN
• DEXAMETHASONE
• CHOLECALCIFEROL
• ASCORBIC ACID
• RIBOFLAVIN (VITB2)
• PYRIDOXINE (VITB6)
• VALPROIC ACID
• ACETAMINOPHEN

• Always take MALIRID 7.5MG TABLET with meals for reduced gastric irritation.
• Eye examination prior to and at 3–6 monthly intervals during use is required if patients are receiving Primaquine at continuous high doses for a longer duration.
• It may cause low blood sugar level. Monitor your blood sugar level regularly, if you are diabetic.
• When MALIRID 7.5MG TABLET used long term, your doctor may monitor the amounts of the different types of blood cells in your blood regularly.

• Adequate nutrition is the key to improvement in malaria induced weakness.
• It is important to allow the patient to eat regularly in small amounts to tolerate the food. 
• Increase fluid and protein intake for malaria induced weight loss.
• Proper rest and mosquito-free premises is important for the patient to recover
• Avoid eating fried and processed foods, junk oily and spicy foods can aggravate nausea and can disturb the digestion process in the body.
• High fibre foods like whole-grain cereals must be avoided by malaria patients. Instead, the intake of fruits and pulses should be increased as they provide adequate nutrition